Prestige BioPharma Market Cap

Prestige BioPharma has a market cap or net worth of 170.19 billion as of October 14, 2024. Its market cap has increased by 18.00% in one year.

Market Cap

170.19B

Enterprise Value

122.90B

Revenue

689.08M

Ranking

n/a

PE Ratio

n/a

Stock Price

14,160.00

Market Cap Chart

Since May 28, 2021, Prestige BioPharma's market cap has decreased from 360.58B to 170.19B, a decrease of -52.80%. That is a compound annual growth rate of -19.90%.

Market Cap History

Date	Market Cap	% Change
Oct 14, 2024	170.19B	49.37%
Dec 28, 2023	113.94B	29.33%
Dec 29, 2022	88.10B	-64.84%
Dec 30, 2021	250.60B	-30.50%

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition